Publication | Closed Access

CT20126, a novel immunosuppressant, prevents collagen-induced arthritis through the down-regulation of inflammatory gene expression by inhibiting NF-κB activation

InflammationChronic Inflammatory DiseasesRheumatologyAnti-inflammatoryInflammatory DiseaseImmune RegulationImmunologyOsteoarthritisChronic InflammationCollagen-induced ArthritisInflammatory Rheumatic DiseaseImmune-mediated Inflammatory DiseasesInnate ImmunityInflammatory Gene ExpressionNf-κb ActivationMedicineCell BiologyInflammatory Arthritis